Cost effectiveness of surveillance for GI cancers

QR Code

Cost effectiveness of surveillance for GI cancers

Gastrointestinal (GI) diseases are among the leading causes of death in the world. To reduce the burden of GI diseases, surveillance is recommended for some diseases, including for patients with inflammatory bowel diseases, Barrett's oesophagus, precancerous gastric lesions, colorectal adenoma,...

Full description

Bibliographic Details
Main Authors:	Omidvari, A., Meester, R., Lansdorp_Vogelaar, Iris
Format:	Journal Article
Published:	2016
Online Access:	http://hdl.handle.net/20.500.11937/49932

Similar Items

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)

Utilization of surveillance after Polypectomy in the Medicare population - A cohort study
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2014)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)

Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality
by: Etzioni, R., et al.
Published: (2013)

An Accurate Cancer Incidence in Barrett's Esophagus: A Best Estimate Using Published Data and Modeling
by: Kroep, S., et al.
Published: (2015)

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
by: Meester, R., et al.
Published: (2015)

Comparative economic evaluation of data from the ACRIN national CT colonography trial with three cancer intervention and surveillance modeling network microsimulations
by: Vanness, D., et al.
Published: (2011)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design
by: Rigter, L., et al.
Published: (2017)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Occurrence of Norovirus GI in green and red onion
by: Mohd Sahroni, Noor Hidayah, et al.
Published: (2011)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

Optimising patient risk stratification for colonoscopy screening and surveillance of colorectal cancer: The role for linked data
by: O'Leary, Peter, et al.
Published: (2017)

Effect of a toggle switch mutation in TM6 of the human adenosine A3 receptor on Gi protein-dependent signalling and Gi-independent receptor internalization
by: Stoddart, Leigh A., et al.
Published: (2014)

Blind Channel Identification and Equalization for GI-less OFDM Systems
by: Al-ayyan, Faisal, et al.
Published: (2008)

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device
by: Heberle, C., et al.
Published: (2017)

DiGi.Com: strategies for capturing market share
by: Adham, Khairul Akmaliah, et al.
Published: (2011)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

DiGi Corporate Social Responsibility: A Case Study
by: Abdo, Lina Abdulmalek Saeed
Published: (2010)

DiGi not guaranteed to get 3G spectrum licence
Published: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n09kjes3l1tuir8qli4bba62go